VRTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 515.7 USD 0.22% Market Closed

Market Cap: $130.9B

	Vertex Pharmaceuticals Inc NASDAQ:VRTX	US
	Manulife Financial Corp TSX:MFC	CA
	Redcare Pharmacy NV F:RDC	NL
	Mitsui & Co Ltd OTC:MITSF	JP
	Primo Water Corp TSX:PRMW	US
	Dufry AG OTC:DUFRY	CH
	LNA Sante SA F:2N3	FR
	Trek Metals Ltd ASX:TKM	BM

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

35% > 35%

Exceptional Free Cash Flow Margin

30%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

41% > 30%

Positive ROE

24%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.